Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Statin non-use and the nocebo effect: How can your patient’s reticence be overcome?
+Practice
In print
HEARTBEAT
Statin non-use and the nocebo effect: How can your patient’s reticence be overcome?
Wednesday 3 March 2021, 12:25 AM

Consultant cardiologist Chris Ellis discusses how to address a patient’s concerns about statin side effects, and the evidence and strategies useful to reassure them
Key points, Significant and harmful rhabdomyolysis with statin use is very rare.
Between 85 and 95 per cent of patients using a statin have no difficulty with , Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
- Nissen SE, Stroes E, Dent-Acosta RE, et al. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: The GAUSS-3 randomized clinical trial. JAMA 2016;315(5):1580–90.
- Wood FA, Howard JP, Finegold JA, et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects. N Engl J Med 2020;383(22):2182–84.